Olga Y. Gorlova

ORCID: 0000-0001-8241-6322
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Associations and Epidemiology
  • Systemic Sclerosis and Related Diseases
  • Lung Cancer Treatments and Mutations
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • Lung Cancer Diagnosis and Treatment
  • Global Cancer Incidence and Screening
  • Bioinformatics and Genomic Networks
  • Celiac Disease Research and Management
  • Molecular Biology Techniques and Applications
  • Evolution and Genetic Dynamics
  • Genetic Mapping and Diversity in Plants and Animals
  • Genomics and Rare Diseases
  • RNA Research and Splicing
  • Colorectal Cancer Screening and Detection
  • Cancer-related molecular mechanisms research
  • RNA and protein synthesis mechanisms
  • Cancer-related gene regulation
  • Systemic Lupus Erythematosus Research
  • Genetic Syndromes and Imprinting
  • Gene expression and cancer classification
  • Genomics and Chromatin Dynamics
  • Radiomics and Machine Learning in Medical Imaging
  • BRCA gene mutations in cancer

Baylor College of Medicine
2011-2025

Houston Institute for Clinical Research
2020-2024

Dartmouth College
2013-2023

Dartmouth–Hitchcock Medical Center
2015-2022

The University of Texas MD Anderson Cancer Center
2005-2020

Vitebsk State Academy of Veterinary Medicine
2019

Moscow Institute of Physics and Technology
2014

Cotton (United States)
2013

Feinstein Institute for Medical Research
2012

Brown Foundation
2012

The aim of this study was to determine, through a genome-wide association (GWAS), the genetic components contributing different clinical sub-phenotypes systemic sclerosis (SSc). We considered limited (lcSSc) and diffuse (dcSSc) cutaneous involvement, relationships with presence SSc-specific auto-antibodies, anti-centromere (ACA), anti-topoisomerase I (ATA). Four GWAS cohorts, comprising 2,296 SSc patients 5,171 healthy controls, were meta-analyzed looking for associations in selected...

10.1371/journal.pgen.1002178 article EN cc-by PLoS Genetics 2011-07-14
Maureen D. Mayes Lara Bossini‐Castillo Olga Y. Gorlova José-Ezequiel Martín Xiaodong Zhou and 95 more Wei V. Chen Shervin Assassi Binwu Ying Filemon K. Tan Frank C. Arnett John D. Reveille Sandra G. Guerra María Teruel F. David Carmona Peter K. Gregersen Annette T. Lee Elena López‐Isac Eguzkine Ochoa Patrícia Carreira Carmen Pilar Simeón‐Aznar I. Castellví Miguel Á. González‐Gay Alexandra Zhernakova Leonid Padyukov Marta E. Alarcón‐Riquelme Cisca Wijmenga Matthew A. Brown Lorenzo Beretta Gabriela Riemekasten Torsten Witte Nicolas Hunzelmann Alexander Kreuter Jörg H. W. Distler Alexandre E. Voskuyl Annemie J. Schuerwegh Roger Hesselstrand Annica Nordin Paolo Airò Claudio Lunardi Paul G. Shiels Jacob M. van Laar Ariane L. Herrick Jane Worthington Christopher P. Denton Fredrick M. Wigley Laura K. Hummers John Varga Monique Hinchcliff Murray Baron Marie Hudson Janet Pope Daniel E. Furst Dinesh Khanna Kristin Phillips Elena Schiopu Barbara Segal Jerry A. Molitor Richard M. Silver Virginia Steen Robert W. Simms Robert Lafyatis Barri J. Fessler Tracy Frech Firas Alkassab Peter Docherty Elżbieta Kamińska Nader Khalidi Henry Niall Jones Janet Markland David Robinson Jasper Broen Timothy R. D. J. Radstake Carmen Fonseca Bobby P. C. Koeleman Javier Martı́n Norberto Ortego‐Centeno Raquel Ríos José Luis Callejas‐Rubio Nuria Navarrete Navarrete Rosa García Portales María Teresa Camps Antonio Fernández‐Nebro María Francisca González‐Escribano Julio Sánchez-Román Francisco José García Hernández María Jesús Castillo M. Á. Aguirre Inmaculada Gómez-Gracia Benjamín Fernández‐Gutiérrez Luis Rodríguez‐Rodríguez Esther Vicente José Luís Andreu M. Fernández Castro Paloma García de la Peña Francisco Javier López-Longo L. Martínez V Fonollosa Gerard Espinosa Carlos Tolosa A. Pros

10.1016/j.ajhg.2013.12.002 article EN publisher-specific-oa The American Journal of Human Genetics 2014-01-01

BackgroundConsiderable effort has been expended on tobacco control strategies in the United States since mid-1950s. However, we have little quantitative information how changes smoking behaviors impacted lung cancer mortality. We quantified cumulative impact of that started mid-1950s mortality over period 1975–2000.

10.1093/jnci/djs136 article EN cc-by-nc JNCI Journal of the National Cancer Institute 2012-03-14

<h3>Objective</h3> The first genome-wide association study (GWAS) of systemic sclerosis (SSc) demonstrated three non-major histocompatibility complex (MHC) susceptibility loci. goal this was to investigate the impact these gene variants on survival and severity interstitial lung disease (ILD) in SSc. <h3>Methods</h3> authors examined 1443 Caucasian SSc patients enrolled <b><i>G</i></b>enetics versus <b><i>E</i></b>nvironment <b><i>I</i></b>n <b><i>S</i></b>cleroderma <b><i>O</i></b>utcome...

10.1136/annrheumdis-2011-200901 article EN Annals of the Rheumatic Diseases 2012-03-22

Exploiting genotyping, DNA sequencing, imputation and trans-ancestral mapping, we used Bayesian frequentist approaches to model the IRF5–TNPO3 locus association, now implicated in two immunotherapies seven autoimmune diseases. Specifically, systemic lupus erythematosus (SLE), resolved separate associations IRF5 promoter (all ancestries) with an extended European haplotype. We captured 3230 high-quality, common variants across 5 ethnicities 8395 SLE cases 7367 controls. The genetic effect...

10.1093/hmg/ddu455 article EN public-domain Human Molecular Genetics 2014-09-08

A single-nucleotide polymorphism (SNP) at the IL12RB2 locus showed a suggestive association signal in previously published genome-wide study (GWAS) systemic sclerosis (SSc). Aiming to reveal possible implication of gene SSc, we conducted follow-up this different Caucasian cohorts. We analyzed 10 GWAS-genotyped SNPs region (2309 SSc patients and 5161 controls). then selected three (rs3790567, rs3790566 rs924080) based on their significance level GWAS, for an independent European cohort...

10.1093/hmg/ddr522 article EN Human Molecular Genetics 2011-11-10

The existence of introns in eukaryotic genes is believed to provide an evolutionary advantage by increasing protein diversity through exon shuffling and alternative splicing. However, this feature associated with the necessity exclusion intronic sequences, which requires considerable energy expenditure can lead splicing errors. relationship between burden evolution poorly understood. goal study was analyze level conservation gene.We found a positive correlation gene its burden. estimated...

10.1186/1471-2148-14-50 article EN cc-by BMC Evolutionary Biology 2014-01-01
Xuemei Ji Yohan Bossé Maria Teresa Landi Jiang Gui Xiangjun Xiao and 95 more David C. Qian Philippe Joubert Maxime Lamontagne Yafang Li Ivan P. Gorlov Mariella De Biasi Younghun Han Olga Y. Gorlova Rayjean J. Hung Xifeng Wu James McKay Xuchen Zong Robert Carreras‐Torres David C. Christiani Neil E. Caporaso Mattias Johansson Geoffrey Liu Stig E. Bojesen Loı̈c Le Marchand Demetrius Albanes Heike Bickeböller Melinda C. Aldrich William S. Bush Adonina Tardón Gad Rennert Chu Chen M. Dawn Teare John K. Field Lambertus A. Kiemeney Philip Lazarus Aage Haugen Stephen Lam Matthew B. Schabath Angeline S. Andrew Hongbing Shen Yun‐Chul Hong Jian‐Min Yuan Pier Alberto Bertazzi Angela Cecilia Pesatori Yuanqing Ye Nancy Diao Li Su Ruyang Zhang Yonathan Brhane Natasha B. Leighl Jakob Sidenius Johansen Anders Mellemgaard Walid Saliba Christopher A. Haiman Lynne R. Wilkens Ana Fernández‐Somoano Guillermo Fernández‐Tardón Erik H.F.M. van der Heijden Jin Hee Kim Juncheng Dai Zhibin Hu Michael Davies Michael W. Marcus Hans Brunnström Jonas Manjer Olle Melander David C. Muller Kim Overvad Antonia Trichopoulou ­Rosario ­Tumino Jennifer A. Doherty Gary E. Goodman Angela Cox Fiona Taylor Penella J. Woll Irene Brüske Judith Manz Thomas Muley Angela Risch Albert Rosenberger Kjell Grankvist Mikael Johansson Frances A. Shepherd Ming‐Sound Tsao Susanne M. Arnold Eric B. Haura Ciprian Bolca Ivana Holcátová Vladimí­r Janout Milica Kontić Jolanta Lissowska Anush Mukeria Simona Ognjanovic Tadeusz Orłowski Ghislaine Scélo Beata Świątkowska Давид Заридзе Per Bakke Vidar Skaug Shanbeh Zienolddiny

Genome-wide association studies (GWAS) identified the chromosome 15q25.1 locus as a leading susceptibility region for lung cancer. However, pathogenic pathways, through which SNPs within affects cancer risk, have not been explored. We analyzed three cohorts with GWAS data consisting 42,901 individuals and expression quantitative trait loci (eQTL) on 409 to identify validate underlying pathways investigate combined effect of genes from pathways. The KEGG neuroactive ligand receptor...

10.1038/s41467-018-05074-y article EN cc-by Nature Communications 2018-08-07

Abstract We performed an analysis of potential epidemiological risk factors for lung cancer using data from 280 cases and 242 hospital‐based controls, all lifetime never smokers (those who had smoked &lt;100 cigarettes in their lifetimes) frequency matched on age, gender ethnicity. The demographic characteristics, medical history respiratory diseases (asthma, emphysema, pneumonia hay fever), weight height, family history, female characteristics environmental tobacco smoke (ETS) dust exposure...

10.1002/ijc.21561 article EN International Journal of Cancer 2005-10-10

Abstract The authors evaluated the familial aggregation of lung and other cancers in first‐degree relatives cancer patients self‐reported to be lifetime never smokers. data, derived from a large case–control study, included 2,465 316 smoker cases 2,441 318 controls, frequency matched on age, gender ethnicity. median age controls was 61 years, about 2/3 were women, 80% Caucasian. Overall, there 25% excess risk [95% CI (1.05–1.50)] any type among cases, case offspring exhibited 2‐fold...

10.1002/ijc.22615 article EN International Journal of Cancer 2007-02-15

<h3>Introduction</h3> A recent genome-wide association study in European systemic sclerosis (SSc) patients identified three loci (<i>PSORS1C1</i>, <i>TNIP1</i> and <i>RHOB</i>) as novel genetic risk factors for the disease. The aim of this was to replicate previously mentioned findings a large multicentre independent SSc cohort Caucasian ancestry. <h3>Methods</h3> 4389 7611 healthy controls from different countries USA were included study. Six single nucleotide polymorphisms (SNP): rs342070,...

10.1136/annrheumdis-2012-201888 article EN Annals of the Rheumatic Diseases 2012-08-15

Evidence from human and animal research indicates that choline metabolic pathways may be activated during a variety of diseases, including cancer. We report results case-control study 2821 lung cancer cases 2923 controls assessed associations betaine dietary intakes with Using multivariable logistic regression analyses, we significant association between higher intake lower risk varied by smoking status. Specifically, no was observed among never-smokers. However, significantly associated...

10.1371/journal.pone.0054561 article EN cc-by PLoS ONE 2013-02-01

Suboptimal cellular DNA repair capacity (DRC) has been shown to be associated with enhanced cancer risk, but genetic variants affecting the DRC phenotype have not comprehensively investigated. In this study, available data, we analyzed correlations between and genotypes detected by Illumina 317K platform in 1,774 individuals of European ancestry from a Texas lung genome-wide association study. The discovery phase was followed replication an independent set 1,374 cases controls ancestry. We...

10.1158/0008-5472.can-12-1915 article EN Cancer Research 2012-10-30
Xuemei Ji Semanti Mukherjee Maria Teresa Landi Yohan Bossé Philippe Joubert and 95 more Dakai Zhu Ivan P. Gorlov Xiangjun Xiao Younghun Han Olga Y. Gorlova Rayjean J. Hung Yonathan Brhane Robert Carreras‐Torres David C. Christiani Neil E. Caporaso Mattias Johansson Geoffrey Liu Stig E. Bojesen Loı̈c Le Marchand Demetrius Albanes Heike Bickeböller Melinda C. Aldrich William S. Bush Adonina Tardón Gad Rennert Chu Chen Jinyoung Byun Konstantin H. Dragnev John K. Field Lambertus FA. Kiemeney Philip Lazarus Shan Zienolddiny Stephen Lam Matthew B. Schabath Angeline S. Andrew Pier Alberto Bertazzi Angela Cecilia Pesatori Nancy Diao Li Su Lei Song Ruyang Zhang Natasha B. Leighl Jakob Sidenius Johansen Anders Mellemgaard Walid Saliba Christopher A. Haiman Lynne R. Wilkens Ana Fernández‐Somoano Guillermo Fernández‐Tardón Erik H.F.M. van der Heijden Jin Hee Kim Michael Davies Michael W. Marcus Hans Brunnström Jonas Manjer Olle Melander David C. Muller Kim Overvad Antonia Trichopoulou ­Rosario ­Tumino Gary E. Goodman Angela Cox Fiona Taylor Penella J. Woll Erich Wichmann Thomas Muley Angela Risch Albert Rosenberger Kjell Grankvist Mikael Johansson Frances A. Shepherd Ming‐Sound Tsao Susanne M. Arnold Eric B. Haura Ciprian Bolca Ivana Holcátová Vladimí­r Janout Milica Kontić Jolanta Lissowska Anush Mukeria Simona Ognjanovic Tadeusz Orłowski Ghislaine Scélo Beata Świątkowska Давид Заридзе Per Bakke Vidar Skaug Lesley M. Butler Kenneth Offit Preethi Srinivasan Chaitanya Bandlamudi Matthew D. Hellmann David B. Solit Mark E. Robson Charles M. Rudin Zsofia K. Stadler Barry S. Taylor Michael F. Berger Richard S. Houlston Esther M. John

Abstract Few germline mutations are known to affect lung cancer risk. We performed analyses of rare variants from 39,146 individuals European ancestry and investigated gene expression levels in 7,773 samples. find a large-effect association with an ATM L2307F (rs56009889) mutation adenocarcinoma for discovery (adjusted Odds Ratio = 8.82, P 1.18 × 10 −15 ) replication OR 2.93, 2.22 −3 that is more pronounced females 6.81 3.19 replication). observe excess loss heterozygosity tumors among...

10.1038/s41467-020-15905-6 article EN cc-by Nature Communications 2020-05-11

Objectives It is significant to know how much early detection and screening could reduce the proportion of occult metastases benefit NSCLC patients. Methods We used previously designed validated mathematical models obtain characteristics LC in population including undetectable at time diagnosis. The survival was simulated using functions from Surveillance, Epidemiology End Results (SEER) data stratified by stage. Based on simulations, 35.3% patients diagnosed with stage N0M0 56.9% those N1M0...

10.1371/journal.pone.0313544 article EN cc-by PLoS ONE 2025-01-03
Coming Soon ...